Literature DB >> 1712006

Suppressive activity of interleukin 4 on the induction of antigen-specific cytotoxic T cells in humans.

U Yamashita1, Y Tanaka.   

Abstract

The effect of interleukin 4 (IL 4) on the induction of cytotoxic T cells (CTL) was studied by using human peripheral blood lymphocytes in vitro. IL 4 suppressed the induction of CTL specific for allogeneic antigens in a concentration-dependent manner. However, IL 4 did not suppress proliferative responses induced with allogeneic antigens or mitogens. The suppressive effect of IL 4 on CTL induction was observed when IL 4 was added at the early period of the CTL induction culture, but not at the later period. Furthermore, IL 4 did not suppress the effector function of CTL to target cells. IL 4 suppressed the production of IL 1 by monocytes/macrophages and the production of IL 2 and the expression of IL 2 receptors on T cells. Moreover, IL 4 suppressed the induction of lymphokine-activated killer cells. These results suggest that IL 4 has a suppressive activity on the induction of killer cells in humans.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712006      PMCID: PMC5918469          DOI: 10.1111/j.1349-7006.1991.tb01890.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


concanavalin A cytotoxic T cells fetal calf serum interleukin lymphokine‐activated killer lipopolysaccharide mitomycin C natural killer peripheral blood lymphocytes tritiated thymidine
  29 in total

1.  Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.

Authors:  S B Mizel; J J Oppenheim; D L Rosenstreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

2.  IL-4 down-regulates IL-1 and TNF gene expression in human monocytes.

Authors:  R Essner; K Rhoades; W H McBride; D L Morton; J S Economou
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

3.  Human T cells and interleukin 4 inhibit the release of interleukin 1 induced by lipopolysaccharide in serum-free cultures of autologous monocytes.

Authors:  L Weiss; N Haeffner-Cavaillon; M Laude; J M Cavaillon; M D Kazatchkine
Journal:  Eur J Immunol       Date:  1989-07       Impact factor: 5.532

4.  Two distinct factors are required for induction of T-cell growth.

Authors:  E L Larsson; N N Iscove; A Coutinho
Journal:  Nature       Date:  1980-02-14       Impact factor: 49.962

5.  Role of B cell stimulatory factor 1/interleukin 4 in clonal proliferation of B cells.

Authors:  C Peschel; I Green; J Ohara; W E Paul
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

6.  Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages.

Authors:  A Zlotnik; M Fischer; N Roehm; D Zipori
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

7.  Interleukin 4 (IgG1 induction factor): a multifunctional lymphokine acting also on T cells.

Authors:  E Severinson; T Naito; H Tokumoto; D Fukushima; A Hirano; K Hama; T Honjo
Journal:  Eur J Immunol       Date:  1987-01       Impact factor: 5.532

8.  Expression of interleukin 1 receptors on human peripheral T cells.

Authors:  F Shirakawa; Y Tanaka; T Ota; H Suzuki; S Eto; U Yamashita
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

9.  IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes.

Authors:  Y Kawakami; M C Custer; S A Rosenberg; M T Lotze
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

10.  Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures.

Authors:  J C Cerottini; H D Engers; H R Macdonald; T Brunner
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more
  1 in total

1.  Suppressive effect of Chinese medicinal herb, Acanthopanax gracilistylus, extract on human lymphocytes in vitro.

Authors:  B E Shan; Y Yoshita; T Sugiura; U Yamashita
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.